Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort

被引:0
|
作者
Yvonne Huber
Franziska Bierling
Christian Labenz
Sandra Koch
Irene Schmidtmann
Roman Kloeckner
Sebastian Schotten
Tobias Huber
Hauke Lang
Marcus A. Woerns
Peter R. Galle
Arndt Weinmann
Julia Weinmann-Menke
机构
[1] University Medical Center of the Johannes Gutenberg University Mainz,Clinical Registry Unit (CRU)
[2] University Medical Center of the Johannes Gutenberg University Mainz,Department of Internal Medicine I
[3] University Medical Center of the Johannes Gutenberg University Mainz,Institute of Medical Biostatistics, Epidemiology and Informatics
[4] University Medical Center of the Johannes Gutenberg University Mainz,Department of Diagnostic and Interventional Radiology
[5] University Medical Center of the Johannes Gutenberg University Mainz,Department of General, Visceral and Transplant Surgery
来源
BMC Cancer | / 18卷
关键词
Hepatocellular carcinoma; HCC; Overall survival; Clinical database; IGF-1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy
    Shao, Yu-Yun
    Huang, Chien-Chung
    Lin, Shiou-Der
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    CLINICAL CANCER RESEARCH, 2012, 18 (14) : 3992 - 3997
  • [22] Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma
    Karabulut, Senem
    Aykan, Nuri Faruk
    Yildiz, Ibrahim
    Kilic, Leyla
    Sen, Fatma
    Vatansever, Sezai
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [23] The change of insulin-like growth factor-1 in diabetic patients with neuropathy
    郭淮莲
    杨毅
    耿稚萍
    朱良湘
    袁申元
    赵毅
    高玉红
    付汉菁
    ChineseMedicalJournal, 1999, (01)
  • [24] The insulin-like growth factor-1 and myocardium remodeling in hypertensive patients
    Zhuravlyova, L. V.
    Kovalyova, O. N.
    JOURNAL OF HYPERTENSION, 2006, 24 : S41 - S41
  • [25] The change of insulin-like growth factor-1 in diabetic patients with neuropathy
    郭淮莲
    杨毅
    耿稚萍
    朱良湘
    袁申元
    赵毅
    高玉红
    付汉菁
    中华医学杂志(英文版), 1999, (01) : 77 - 80
  • [26] The change of insulin-like growth factor-1 in diabetic patients with neuropathy
    Guo, HL
    Yang, Y
    Geng, ZP
    Zhu, LX
    Yuan, SY
    Zhao, Y
    Gao, YH
    Fu, HJ
    CHINESE MEDICAL JOURNAL, 1999, 112 (01) : 76 - 79
  • [27] Reduced insulin-like growth factor-1 in patients with syndrome X
    Conti, E
    Andreotti, F
    Lanza, GA
    Riccardi, P
    Sestito, A
    Sciahbasi, A
    Fischetii, D
    Menini, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 356A - 356A
  • [28] Insulin-like growth factor-1 as a vascular protective factor
    Conti, E
    Carrozza, C
    Capoluongo, E
    Volpe, M
    Crea, F
    Zuppi, C
    Andreotti, F
    CIRCULATION, 2004, 110 (15) : 2260 - 2265
  • [29] Insulin-like growth factor-1 induces epithelial-mesenchymal transition in hepatocellular carcinoma by activating survivin
    Liu, Fangfeng
    Sun, Yongjie
    Liu, Bingqi
    Lu, Jun
    Li, Hongguang
    Zhu, Huaqiang
    Gao, Hengjun
    Zhou, Xu
    Chang, Hong
    ONCOLOGY REPORTS, 2018, 40 (02) : 952 - 958
  • [30] Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma
    Karabulut, S.
    Duranyildiz, D.
    Tas, F.
    Gezer, U.
    Akyuz, F.
    Serilmez, M.
    Ozgur, E.
    Yasasever, C. T.
    Vatansever, S.
    Aykan, N. F.
    TUMOR BIOLOGY, 2014, 35 (03) : 2729 - 2739